Market News & Trends
Elite Pharmaceuticals Announces Positive Top-Line Results
Elite Pharmaceuticals, Inc. recently announced positive top-line results from the Phase III pivotal trial of its lead opioid abuse-deterrent candidate, ELI-200, for the treatment of…
Honeywell to Acquire Research Chemicals Business From Sigma-Aldrich
Honeywell recently announced it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.…
EMD Millipore to Provide Provantage End-to-End Solution for Development & Manufacture of Biosimilars Under Strategic Alliance
EMD Millipore recently announced it has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their…
CytoDyn Injects First Patient in Its Current Phase III Study
CytoDyn Inc. recently announced that the first patient in its Phase III clinical trial has been injected with PRO 140, the company's monoclonal antibody for…
BioXcel Initiates Strategic Big Data Partnership With Pronutria
BioXcel Corporation recently announced the initiation of a strategic big data collaboration with Pronutria Biosciences to identify diseases characterized by high unmet need for therapies…
New Jersey Company Seeks Formulation Scientist
Title: Formulation Scientist Position Type: Full-time Department: Research and Development Reports To: Sr. Director of Formulation Effective Date: Ongoing Location: New Jersey Salary: $100K or…
Scientific Posters at BPI Spotlight Cutting-Edge Research
— 2015 BioProcess International Conference & Expo Unveils Over 100 Peer-Submitted Scientific Posters Featuring Innovative Concepts and Solutions…
Zealand Meets Development Milestone in Collaboration With Boehringer Ingelheim
Zealand recently announced that Boehringer Ingelheim has selected a novel peptide therapeutic to be advanced into preclinical development under one of two ongoing collaboration agreements…
Opsonix is Launched to Develop Pathogen-Extracting Therapy
Opsonix, Inc. recently announced the company’s launch with an $8-million Series A financing to develop a pathogen-extracting therapy designed to remove infectious pathogens and toxins…
Codexis Earns $6.5-Million Milestone From GSK
Codexis, Inc. recently announced it successfully completed Wave 2 of the transfer of its proprietary CodeEvolver protein engineering platform technology to GlaxoSmithKline (GSK) in the…
Emisphere Signs Lucrative License Agreement With Novo Nordisk
Emisphere Technologies, Inc. recently announced it has entered into a Development and License Agreement with Novo Nordisk A/S to develop and commercialize oral formulations of…
West Launches New Ready-to-Use/Validated Components
West Pharmaceutical Services, Inc. recently launched Daikyo RUV (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe 2015 in Madrid, Spain. In addition, West is showcasing a range…
Ajinomoto Althea Expands Manufacturing Capabilities to ADC Fill Finish & Bioconjugation
Ajinomoto Althea, Inc. recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates…
Realizing Process Innovation in Aseptic Manufacturing: An Improved RABS Concept
(Bio-)pharmaceutical service providers in their role of manufacturing complex drug products face a difficult challenge in providing reliable and repeatable aseptic processes for ever-decreasing batch…
Astellas Pharma & Immunomic Therapeutics Announce $300-Million Worldwide Partnership for LAMP-vax Products
Immunomic Therapeutics, Inc. and Astellas Pharma Inc. recently announced they have entered into an exclusive worldwide license agreement to the LAMP-vax products for the treatment…
Enable Injections Introduces Mobile Monitoring & Larger Volume Capabilities to its Wearable Injectors
Enable Injections, the developer and manufacturer of a new wearable injector technology platform that allows patients to comfortably and easily self-administer large volume drugs subcutaneously,…
Capsugel Expands Its Successful DRcaps Capsule Platform With New Liquid-Fill Capability
Capsugel recently announced it has developed a technology that makes its vegetarian, acid-resistant DRcaps hard capsules suitable for liquid-fill applications. As a result, Capsugel’s customers…
Baxalta & Momenta Announce Initiation of Pivotal Clinical Trial for Biosimilar
Baxalta Incorporated and Momenta Pharmaceuticals, Inc. recently announced the initiation of a pivotal clinical trial in patients with chronic plaque psoriasis for M923, a biosimilar…
Merck Millipore Adds Protein Pegylation to Portfolio of Services Through Collaboration
Merck Millipore recently announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars. The new service offering enabled…
Ergomed Significantly Increases Contribution in CEL-SCI’s Phase III Trial
CEL-SCI Corporation and its Clinical Research Organization (CRO) Ergomed plc recently announced they have expanded their co-development agreement with increased activities to be undertaken by…
